Director/PDMR Shareholding

RNS Number : 5260N

Hikma Pharmaceuticals Plc

20 May 2020

 

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 20 May 2020: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 16 May 2018 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 19 May 2020.  

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 16,953
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 22,601
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

Majda Labadi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Majda Labadi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 15,855
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

 Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 25,729
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

  Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 23,062
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

  Brian Hoffmann

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian Hoffmann
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 18,247
d)	Aggregated information	N/A
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)	Price(s) and volume(s)	Price(s): £24.629 Volume(s): 13,489
d)	Aggregated information	Aggregated volume: 13,489 Price: £332,220.58
e)	Date of the transaction	19 May 2020
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

 

END

 

 

DSHBSGDUGSDDGGG